-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We raise our target by $1 to $30 using a forward P/EBITDA of 31.3x our 2026 EBITDA estimate of $120M, in line with the three-year forward TEV/EBITDA average. We think our multiple is justified by store growth runway and intelligent eyewear potential offsetting consumer discounting. We raise our 2026 EPS estimate by $0.07 to $0.50 and increase 2027's by $0.02 to $0.65. Our revenue projections are $975M in 2026 and $1.1B in 2027, respectively. Given the outsize gain in the share price today, we think the upside potential may be limited to our view of fair value, which is our target price. We don't believe WRBY should have a wider equity risk premium as we applied a P/EBITDA multiple. In our view, revenue growth Y/Y in 2026-2027 is not commensurate with an even higher multiple valuation. Nonetheless, WRBY has a proven business model in a highly competitive market: the retail eyewear market. We are skeptical that innovation with smart eyeglasses will make a big difference to net sales in the next year.